Carisma Therapeutics Inc. Business Combination, Contingent Consideration, Liability
Carisma Therapeutics Inc. had Business Combination, Contingent Consideration, Liability of $0 as of 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2023-02-28
- 2022-12-31: Business Combination, Contingent Consideration, Liability $0.00.
- 2022-09-30: Business Combination, Contingent Consideration, Liability $0.00.
- 2022-06-30: Business Combination, Contingent Consideration, Liability $1.80M.
- 2021-12-31: Business Combination, Contingent Consideration, Liability $52.00M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-28 |
| 2022-09-30 | $0.00 10-K · filed 2023-02-28 |
| 2022-06-30 | $1.80M 10-K · filed 2023-02-28 |
| 2021-12-31 | $52.00M 10-K · filed 2022-02-28 |
| 2021-09-30 | $56.60M 10-K · filed 2022-02-28 |
| 2021-06-30 | $170.60M 10-K · filed 2022-02-28 |
| 2021-03-31 | $157.00M 10-K · filed 2022-02-28 |
| 2020-12-31 | $108.84M 10-K · filed 2022-02-28 |
| 2020-09-30 | $103.20M 10-K · filed 2021-03-15 |
| 2020-06-30 | $84.80M 10-K · filed 2021-03-15 |
| 2020-03-31 | $66.32M 10-K · filed 2021-03-15 |